Compare AAPG & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AAPG | VIRT |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.8B |
| IPO Year | 2025 | 2015 |
| Metric | AAPG | VIRT |
|---|---|---|
| Price | $30.00 | $35.42 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 7 |
| Target Price | ★ $48.50 | $41.43 |
| AVG Volume (30 Days) | 5.1K | ★ 732.9K |
| Earning Date | 11-19-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 2.71% |
| EPS Growth | N/A | ★ 132.69 |
| EPS | N/A | ★ 4.62 |
| Revenue | $54,524,554.00 | ★ $2,694,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $368.64 | N/A |
| P/E Ratio | ★ N/A | $7.67 |
| Revenue Growth | N/A | ★ 41.05 |
| 52 Week Low | $16.50 | $31.89 |
| 52 Week High | $48.45 | $45.77 |
| Indicator | AAPG | VIRT |
|---|---|---|
| Relative Strength Index (RSI) | 50.39 | 55.14 |
| Support Level | $30.00 | $34.16 |
| Resistance Level | $33.09 | $35.89 |
| Average True Range (ATR) | 0.83 | 0.85 |
| MACD | 0.14 | 0.08 |
| Stochastic Oscillator | 72.07 | 77.99 |
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.